|
Skin is remarkable
Skin not only protects us but provides
valuable functions to every man, woman and
child. So remarkable is skin that SWITCH
Biotech is committed to make it part of our
science.
Knowledge and expertise
SWITCH Biotech uses its broad knowledge and
expertise of the molecular biology of the skin
to develop drugs for various skin disorders.
By using proprietary technology SWITCH can rapidly
profile potential new and re-profile existing
compounds for possible treatments for a variety
of diseases.
Therapeutic areas of interest include --
Psoriasis, Atopic Dermatitis, Vitiligo,
Androgenic Alopecia and other non-dermatologic
areas.
|
|
Use of functional genomics
By using functional genomics, SWITCH
Biotech's goal is to identify key targets
involved in skin diseases.
We have gained comprehensive knowledge about
the molecular biology of skin and have developed
novel approaches to the development of new drugs
by validating targets, assays and compounds.
The result of this platform in total is the
ability to develop and discover
"mechanism-based" therapeutics that can treat a
variety of dermatological diseases and other
indications.
Unique discovery platform
SWITCH Biotech's
proprietary technology is unique to the
dermatology industry.
SWITCH has the ability to utilize computer
based programs to reduce the traditional drug
discovery process to a fraction of its time
through rapid identification of chemical
compounds.
|
|
A leader in
biotech research
SWITCH Biotech is leading the way as
a leader of biotech companies to specialize
in dermatological related areas.
SWITCH has developed one of the largest
pools of knowledge and expertise concerning
the molecular biology of the skin which in
the future could treat various skin
diseases.
|
